Having trouble accessing articles? Reset your cache.

Putting fibromyalgia to sleep

Two drugs are approved in the U.S. to treat fibromyalgia. But given the long list of symptoms associated with the disorder, Jazz Pharmaceuticals Inc. believes there is plenty of room for new drugs to help manage the pain and fatigue that characterize the disease. The company now has positive data in hand from its first Phase III trial of JZP-6, and anticipates it will complete enrollment in a second Phase III study by year end.

In 1990, the American College of Rheumatology developed criteria for diagnosing fibromyalgia

Read the full 869 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE